Results 51 to 60 of about 11,390 (207)

Not Only Enteropathy: The Overlooked “Gastric Side” of Olmesartan

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Several medications can be associated with gastrointestinal adverse effects. Olmesartan has been linked to a broad spectrum of gastrointestinal injuries. Although sprue‐like enteropathy is well known, less common involvements such as gastropathy can be equally debilitating.
Cecilia Lina Pugliano, Stefania Piccirelli, Denise Bianchi, Clarissa Ferrari, Cristiano Spada, Paola Cesaro   +5 more
wiley   +1 more source

Evaluation and Comparison of Anticonvulsant Activity of Telmisartan and Olmesartan in Experimentally Induced Animal Models of Epilepsy [PDF]

Journal of Clinical and Diagnostic Research, 2014
Background: Epilepsy is one common neurological disorder requiring newer targets and newer drugs for its efficient management. In the recent days brain renin angiotensin system has gained immense importance because of its involvement in seizure ...
Pushpa V H, Padmaja Shetty K, Suresha R N, Jayanthi M K, Ashwini V, Vaibhavi P S   +5 more
doaj   +1 more source

Spatial Variability in Trace Organic Compound Reactivity During Urban River Infiltration Into an Alluvial Aquifer

Water Resources Research, Volume 62, Issue 5, May 2026.
Abstract Trace organic compounds (TrOCs) in lotic systems pose risks for ecosystem and human health. TrOCs can enter groundwater along losing river sections, yet little is known about the spatial extent of infiltration zones and the biogeochemical factors controlling the spatial variability of TrOC reactivity and removal, particularly along river‐to ...
Jonas L. Schaper, Olaf A. Cirpka, Malte Posselt, Joerg Lewandowski, Karin Meinikmann, Anke Putschew, Christiane Zarfl   +6 more
wiley   +1 more source

Oxidative stress in the brain and arterial hypertension [PDF]

, 2009
Universidade Federal de São Paulo, Dept Physiol, BR-04023060 São Paulo, BrazilUniversidade Federal de São Paulo, Dept Physiol, BR-04023060 São Paulo, BrazilWeb of ...
C Berry, EB Oliveira-Sales, J Peterson, KK Griendling, MC Zimmerman, RR Campos, Ruy R Campos, S Araki, SH Chan, T Kishi   +9 more
core   +1 more source

Risk of Acute Kidney Injury Associated With Nephrotoxic Burden in Hospitalized Patients: A Scoping Review

Clinical Pharmacology &Therapeutics, Volume 119, Issue 4, Page 891-904, April 2026.
Limited evidence exists synthesizing the risk of acute kidney injury (AKI) associated with the concomitant administration of multiple nephrotoxic drugs, and even less examining the concept of nephrotoxic burden. The objective of this scoping review was to (1) identify definitions of nephrotoxic burden; (2) methods used to quantify (use of calculations)
Wafa Alatawi, Jessica L. Wallace, Dhakrit Rungkitwattanakul, Britney A. Stottlemyer, Tiffany L. Tran, Melanie Manis Reida, Sandra L. Kane‐Gill   +6 more
wiley   +1 more source

Cardiac overexpression of constitutively active Galpha q causes angiotensin II type1 receptor activation, leading to progressive heart failure and ventricular arrhythmias in transgenic mice. [PDF]

PLoS ONE, 2014
Transgenic mice with transient cardiac expression of constitutively active Galpha q (Gαq-TG) exhibt progressive heart failure and ventricular arrhythmias after the initiating stimulus of transfected constitutively active Gαq becomes undetectable. However,
Naoko Matsushita, Toshihide Kashihara, Hisashi Shimojo, Satoshi Suzuki, Tsutomu Nakada, Yasuchika Takeishi, Ulrike Mende, Eiichi Taira, Mitsuhiko Yamada, Atsushi Sanbe, Masamichi Hirose   +10 more
doaj   +1 more source

Olmesartan-associated Enteropathy with Acute Kidney Injury

The Korean Journal of Gastroenterology, 2022
Olmesartan, a recently introduced angiotensin II receptor blocker for hypertension, has been reported to cause drug-induced small bowel enteropathy. The diagnosis of olmesartan-associated enteropathy (OAE) needs clinical suspicion and the exclusion of ...
Moo Jin Kang, Kyung Hwa Min, Hyung Wook Kim, Su Bum Park, Dae Hwan Kang, Cheol Woong Choi, Su Jin Kim, Hyeong Seok Nam, Dae Gon Ryu   +8 more
doaj   +1 more source

Fixed combinations in the management of hypertension: Patient perspectives and rationale for development and utility of the olmesartan – amlodipine combination [PDF]

, 2008
Although the awareness and control of hypertension has increased, only 37% of hypertensive patients in the US achieve the conservative goal ...
Pimenta, Eduardo, Oparil, Suzanne
core   +2 more sources

ANTIHYPERTENSIVE EFFICACY OF OLMESARTAN MEDOXOMIL, A NEW ANGIOTENSIN II RECEPTOR ANTAGONIST, AS ASSESSED BY AMBULATORY BLOOD PRESSURE MEASUREMENTS

Российский кардиологический журнал, 2011
Olmesartan medoxomil is a new angiotensin II receptor blocker. In this randomized, double-blind, placebo-controlled study, the efficacy and safety of olmesartan medoxomil was assessed in 334 patients with moderate to severe essential hypertension ...
J. M. Neutel, W. J. Elliott, J. L. Izzo, C. L. Chen, H. N. Masonson   +4 more
doaj  

Effect of Nebivolol and Olmesartan on 24-Hour Brachial and Aortic Blood Pressure in the Acute Stage of Ischemic Stroke

International Journal of Hypertension, 2019
Background. Elevated blood pressure (BP) in the acute phase of ischemic stroke is associated with heightened risk of early disability and death. However, whether BP-lowering in this setting is beneficial and the exact levels at which BP should be ...
Eleni Georgianou, Panagiotis I. Georgianos, Konstantinos Petidis, Konstantinos Markakis, Ioanna Zografou, Asterios Karagiannis   +5 more
doaj   +1 more source